Kyu-Man Han1, Aram Kim2, Wooyoung Kang2, Youbin Kang2, June Kang3, Eunsoo Won1, Woo-Suk Tae4, Byung-Joo Ham5. 1. Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea. 2. Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea. 3. Department of Brain and Cognitive Engineering, Korea University, Seoul, Republic of Korea. 4. Brain Convergence Research Center, Korea University Anam Hospital, Seoul, Republic of Korea. 5. Department of Psychiatry, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Republic of Korea; Brain Convergence Research Center, Korea University Anam Hospital, Seoul, Republic of Korea. Electronic address: hambj@korea.ac.kr.
Abstract
BACKGROUND: The hippocampus is not a uniform structure, but rather consists of multiple, functionally specialized subfields. Few studies have explored hippocampal subfield volume difference in the same sample of major depressive disorder (MDD) and bipolar disorder (BD) cases. We aimed to investigate the difference of hippocampal subfield volume between patents with MDD and BD and healthy controls (HCs). METHODS: A total of 102 MDD and 55 BD patients and 135 HCs were recruited and underwent T1-weighted image. Hippocampal subfield volume was calculated by automated segmentation and volumetric procedures developed by Iglesias et al. and implemented in FreeSurfer. Volume differences between the groups were analyzed using the analysis of covariance and controlling for age, sex, and total intracranial cavity volume. RESULTS: Patients with MDD had significantly reduced volumes in the bilateral cornu ammonis 1 (CA1), CA4, the granule cell layer (GCL), molecular layer (ML), whole hippocampus, the left CA2/3, and right presubiclum and subiculum. Patients with BD had significantly reduced volumes in the right CA1, GCL, and the whole hippocampus as compared to HCs. No significant volume differences were observed between the MDD and BD groups. Illness duration was negatively correlated with volumes of the left CA1, CA4, ML, presubiculum, subiculum, and the whole hippocampus in patients with BD. CONCLUSION: We observed hippocampal subfield volume reductions in both MDD and BD, a finding which more prominent in MDD. The inverse correlation between BD illness duration and hippocampal subfield volume may evidence the neuroprogressive nature of BD.
BACKGROUND: The hippocampus is not a uniform structure, but rather consists of multiple, functionally specialized subfields. Few studies have explored hippocampal subfield volume difference in the same sample of major depressive disorder (MDD) and bipolar disorder (BD) cases. We aimed to investigate the difference of hippocampal subfield volume between patents with MDD and BD and healthy controls (HCs). METHODS: A total of 102 MDD and 55 BD patients and 135 HCs were recruited and underwent T1-weighted image. Hippocampal subfield volume was calculated by automated segmentation and volumetric procedures developed by Iglesias et al. and implemented in FreeSurfer. Volume differences between the groups were analyzed using the analysis of covariance and controlling for age, sex, and total intracranial cavity volume. RESULTS:Patients with MDD had significantly reduced volumes in the bilateral cornu ammonis 1 (CA1), CA4, the granule cell layer (GCL), molecular layer (ML), whole hippocampus, the left CA2/3, and right presubiclum and subiculum. Patients with BD had significantly reduced volumes in the right CA1, GCL, and the whole hippocampus as compared to HCs. No significant volume differences were observed between the MDD and BD groups. Illness duration was negatively correlated with volumes of the left CA1, CA4, ML, presubiculum, subiculum, and the whole hippocampus in patients with BD. CONCLUSION: We observed hippocampal subfield volume reductions in both MDD and BD, a finding which more prominent in MDD. The inverse correlation between BD illness duration and hippocampal subfield volume may evidence the neuroprogressive nature of BD.
Authors: Christoph Kraus; Rene Seiger; Daniela M Pfabigan; Ronald Sladky; Martin Tik; Katharina Paul; Michael Woletz; Gregor Gryglewski; Thomas Vanicek; Arkadiusz Komorowski; Siegfried Kasper; Claus Lamm; Christian Windischberger; Rupert Lanzenberger Journal: Int J Neuropsychopharmacol Date: 2019-08-01 Impact factor: 5.176
Authors: Niels Hansen; Aditya Singh; Claudia Bartels; Frederic Brosseron; Katharina Buerger; Arda C Cetindag; Laura Dobisch; Peter Dechent; Birgit B Ertl-Wagner; Klaus Fliessbach; John D Haynes; Michael T Heneka; Daniel Janowitz; Ingo Kilimann; Christoph Laske; Coraline D Metzger; Matthias H Munk; Oliver Peters; Josef Priller; Nina Roy; Klaus Scheffler; Anja Schneider; Annika Spottke; Eike J Spruth; Stefan Teipel; Maike Tscheuschler; Ruth Vukovich; Jens Wiltfang; Emrah Duezel; Frank Jessen; Roberto Goya-Maldonado Journal: Front Aging Neurosci Date: 2021-04-21 Impact factor: 5.750
Authors: Renata Santos; Sara B Linker; Shani Stern; Ana P D Mendes; Maxim N Shokhirev; Galina Erikson; Lynne Randolph-Moore; Vipula Racha; Yeni Kim; John R Kelsoe; Anne G Bang; M Alda; Maria C Marchetto; Fred H Gage Journal: Mol Psychiatry Date: 2021-01-04 Impact factor: 13.437
Authors: Mark R Etherton; Panagiotis Fotiadis; Anne-Katrin Giese; Juan E Iglesias; Ona Wu; Natalia S Rost Journal: Front Neurol Date: 2020-10-26 Impact factor: 4.003
Authors: Philipp G Sämann; Juan Eugenio Iglesias; Boris Gutman; Dominik Grotegerd; Ramona Leenings; Claas Flint; Udo Dannlowski; Emily K Clarke-Rubright; Rajendra A Morey; Theo G M van Erp; Christopher D Whelan; Laura K M Han; Laura S van Velzen; Bo Cao; Jean C Augustinack; Paul M Thompson; Neda Jahanshad; Lianne Schmaal Journal: Hum Brain Mapp Date: 2020-12-27 Impact factor: 5.038